Similar articles

• Unraveling the Prenylation-Cancer Paradox in Multiple Myeloma with Novel Geranylgeranyl Pyrophosphate Synthase (GGPPS) Inhibitors.

  Lacbay CM, Waller DD, Park J, Gómez Palou M, Vincent F, Huang XF, Ta V, Berghuis AM, Sebag M, Tsantrizos YS. Lacbay CM, et al. J Med Chem. 2018 Aug 9;61(15):6904-6917. doi: 10.1021/acs.jmedchem.8b00886. Epub 2018 Jul 25. J Med Chem. 2018. PMID: 30016091
• Digeranyl bisphosphonate inhibits geranylgeranyl pyrophosphate synthase.

  Wiemer AJ, Tong H, Swanson KM, Hohl RJ. Wiemer AJ, et al. Biochem Biophys Res Commun. 2007 Feb 23;353(4):921-5. doi: 10.1016/j.bbrc.2006.12.094. Epub 2006 Dec 21. Biochem Biophys Res Commun. 2007. PMID: 17208200
• Mono- and dialkyl isoprenoid bisphosphonates as geranylgeranyl diphosphate synthase inhibitors.

  Wiemer AJ, Yu JS, Lamb KM, Hohl RJ, Wiemer DF. Wiemer AJ, et al. Bioorg Med Chem. 2008 Jan 1;16(1):390-9. doi: 10.1016/j.bmc.2007.09.029. Epub 2007 Sep 18. Bioorg Med Chem. 2008. PMID: 17905588
• Recent Advances in the Development of Mammalian Geranylgeranyl Diphosphate Synthase Inhibitors.

  Haney SL, Wills VS, Wiemer DF, Holstein SA. Haney SL, et al. Molecules. 2017 May 27;22(6):886. doi: 10.3390/molecules22060886. Molecules. 2017. PMID: 28555000 Free PMC article. Review.
• Branch-point reactions in the biosynthesis of cholesterol, dolichol, ubiquinone and prenylated proteins.

  Grünler J, Ericsson J, Dallner G. Grünler J, et al. Biochim Biophys Acta. 1994 Jun 2;1212(3):259-77. doi: 10.1016/0005-2760(94)90200-3. Biochim Biophys Acta. 1994. PMID: 8199197 Review. No abstract available.